undamentalytics Newsletter
Sign in

Ocugen, Inc. balance sheet

At the end of fiscal 2025, Ocugen, Inc. had total assets of $43.5m, total liabilities of $55.7m and shareholders' equity of −$12.2m. It held $18.6m in cash against $31.5m of debt: net debt of $12.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents593132727249578395919100
Total current assets59313282162610398436224107
Total assets6537361121727106109658244124
Accounts payable5221320283465
Total current liabilities86541454729172223133
Short-term debt————700000110
Long-term debt————11222327282
Total debt000091222333322
Total liabilities119232215661035245356141
Shareholders' equity5428144−13112291744130−12−17
Non-controlling interests and other (assets − liabilities − equity)———−16———5—————
Net debt (negative = net cash)−59−31−32−77−6−22−93−75−37−2613−98
Shares outstanding13m106m124m172m—105m—199m222m257m291m312m339m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ENSC vs OCGNOCGN vs TRDABOLT vs OCGNCRIS vs OCGN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Ocugen, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ocugen, Inc.